[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346709-105":59,"doc-detail-346709-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","the-research-advances-of-crosstalk-between-cancer-associated-fibroblasts-and-tumor-cells-using-co-culture-organoids","The research advances of crosstalk between cancer-associated fibroblasts and tumor cells using co-culture organoids","","Cancer-associated fibroblasts (CAFs) critically shape tumor cell behavior and contribute to therapy resistance through extensive, context-dependent interactions with cancer cells and other stromal components. Despite CAFs being long viewed as therapeutic targets, clinical trials often fail or even worsen disease progression, reflecting a more dynamic and complex CAF identity and function than previously assumed. This review summarizes 3D co-culture organoid methods combining CAFs and tumor cells and outlines molecular mechanisms regulating CAF heterogeneity, while discussing current strategies that target tumor-promoting CAF subsets and their limitations.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-research-advances-of-crosstalk-between-cancer-associated-fibroblasts-and-tumor-cells-using-co-culture-organoids/346709/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-research-advances-of-crosstalk-between-cancer-associated-fibroblasts-and-tumor-cells-using-co-culture-organoids/346709.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How do CAFs influence tumor cells in the tumor microenvironment?","Question",{"text":113,"@type":114},"CAFs affect tumor cell characteristics and can enhance cancer progression by creating a dense niche. They also contribute to invasion, metastasis, angiogenesis, drug resistance, and cancer stem cell self-renewal via ECM remodeling and other mechanisms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why do clinical trials targeting CAFs often fail or lead to worse outcomes?",{"text":118,"@type":114},"Targeting CAFs has shown inconsistent results, and can even accelerate progression. CAFs are heterogeneous and context-dependent, so broad strategies may disrupt protective stromal functions or miss specific tumor-cell–CAF signaling interactions.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the role of tumor organoids co-cultured with CAFs?",{"text":122,"@type":114},"Tumor organoids co-cultured with CAFs can recapitulate structure and function of solid tumors. They provide a suitable model to clarify CAF–tumor crosstalk mechanisms and support screening of precision targeted drugs.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346709,1790537717,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nREVIEW ARTICLE OPEN   \nThe research advances of crosstalk between cancer-associated ﬁbroblasts and tumor cells using co-culture organoids  \nMinghui Wang 1,2,4, Xiaodi Ding3,4, Lin Chen 1,2, Zhichao Cui3, Yiyi Ding 1, Yongmin Song 1, Wentong Li 3 ✉ and Xumei Zhang 2 ✉  \n© The Author(s) 2026  \n|  |  |  |\n| --- | --- | --- |\n|  | Cancer-associated ﬁbroblasts (CAFs) fundamentally impact on characteristics of tumor cells and are concerned with therapy resistance via extensive interplay with cancer cells and other stromal components. In addition, inherent plasticity and multifunctionality of CAFs enable cancer cells to cultivate them, leading to dynamic changes in the population of CAFs in a contextdependent manner. Despite CAFs have long been regarded as a key participant in cancer development and therefore an appealing therapeutic target, most clinical trials targeting CAFs end in failure, and even accelerate progression of cancers, indicating that dynamic complicated identity and function of CAFs far exceed the current view. Accordingly, analyzing the heterogeneous subgroups and different functions of CAFs in a context dependent mode is of great signiﬁcance. To ascertain the functional interactions between CAFs and cancer cells, various three-dimensional co-culture models of organoid with CAFs and cancer cells from murine or human have been successfully established. In the review, we recapitulate the proposed methods for cultivating organoids consisted of tumor cells and CAFs as well as molecular mechanisms involving in regulating variety of CAF subgroups. Current strategies targeting tumor-promoting CAFs selectively are also discussed, offering perception and perspectives for scientiﬁc |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| investigation and clinical trials concerning various methods targeting CAFs. |  |  |\n|  | Cell Death and Disease (2026)17:267; [https://doi.org/10.1038/s41419-026-08512-8](https://doi.org/10.1038/s41419-026-08512-8) |  |\n|  |  |  |\n\nFACTS AND QUESTIONS  \n1. CAFs experience phenotypic and functional conversion when interplaying with cancer cells and exhibit multifaceted roles, such as enhancing cancer progression and stimulating cancer stem cell properties.  \n2. Strategies targeting CAFs to exploit more effective remedies, such as ECM modulation, direct elimination, interruption of CAFs-tumor crosstalk and CAF normalization, are still unsatisfactory, indicating that dynamic complexities of CAF identity and function are needed further research.  \n3. Tumor organoids co-cultured with CAFs recapitulate structure and function of solid tumors and could be a suitable model for future usage in clarifying crosstalk mechanism between CAFs and tumor cells or other stroma cells and screen of precision targeted drugs.  \nINTRODUCTION  \nTumor microenvironment (TME) has been supposed to be a momentous determinant for tumorigenesis, therapeutic response and prognosis [1], and cancer associated ﬁbroblasts (CAFs) exhibit multifaceted roles in TME [2, 3]. Already in the earliest stage, CAFs  \nfacilitate cancer cell initiation via extracellular matrix (ECM) remodeling [4]. During tumor progression, CAFs are essential for invasion, metastatic spread, angiogenesis, drug resistance and cancer stem cell (CSC) self-renewal by establishing a dense tumor niche [5–7].  \nTargeting CAFs directly appears to be a potential precision intervention in clinical practice; actually, various methods targeting CAFs have displayed inconsistent ﬁndings, even leading to worse outcomes [8]. The heterogeneity of CAFs means that broad-targeting strategies may inadvertently disrupt protective stromal functions or fail to address context-speciﬁc interactions [9]. Moreover, uncharacterized interaction between tumor cell-derived signaling and CAFs differentiation restricts targeted inhibitor development.  \nIn recent years, org","cbCaicdb0SwqWQVc","https://ap.wps.com/l/cbCaicdb0SwqWQVc","pdf",3008213,14,"English","# Facts and Questions\n# Introduction\n# Superiority of Tumor Organoids in Cancer Research\n## Table 1. Advantages and Disadvantages of Different Organoid Models","[{\"question\":\"How do CAFs influence tumor cells in the tumor microenvironment?\",\"answer\":\"CAFs affect tumor cell characteristics and can enhance cancer progression by creating a dense niche. They also contribute to invasion, metastasis, angiogenesis, drug resistance, and cancer stem cell self-renewal via ECM remodeling and other mechanisms.\"},{\"question\":\"Why do clinical trials targeting CAFs often fail or lead to worse outcomes?\",\"answer\":\"Targeting CAFs has shown inconsistent results, and can even accelerate progression. CAFs are heterogeneous and context-dependent, so broad strategies may disrupt protective stromal functions or miss specific tumor-cell–CAF signaling interactions.\"},{\"question\":\"What is the role of tumor organoids co-cultured with CAFs?\",\"answer\":\"Tumor organoids co-cultured with CAFs can recapitulate structure and function of solid tumors. They provide a suitable model to clarify CAF–tumor crosstalk mechanisms and support screening of precision targeted drugs.\"}]","The research advances of crosstalk between cancer-associated fibroblasts and tumor cells using co-culture organoids | PDF",1790062486,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df07e54a8baba6c175103cce67fe88e1.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c04630e705b635d895702c0eddef3d1.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e3c4f54164484c424a5ccb38434a65e1.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f59048490479a629ad0bec9c428ffa3d.webp",980,1301]